Nephrolithiasis clinical trials

Explore recruiting nephrolithiasis clinical trials.

Recruiting nephrolithiasis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Nephrolithiasis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The GranStone Trial - Prevention of Kidney Stones due to Paraffin Oil Induced Granuloma

Denmark

Phase II and Phase III (Integrated) EU CTIS Study details

Effekten av intrathekalt morfin eller intravenöst lidokain på postoperativ återhämtning efter robotassisterad övre urologisk kirurgi. Randomiserad assessor-blindad multicenterstudie.

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

CALIBRATE: A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Encaleret Compared to Standard of Care in Participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1)

Belgium, France, Netherlands, Czechia, Denmark, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

P2-IMU-838-MS - Randomized, double-blind, placebo-controlled, multicenter Phase 2 trial assessing the effect of IMU-838 on disease activity, as measured by magnetic resonance imaging (MRI), as well as safety and tolerability in patients with relapsingremitting multiple sclerosis (RRMS) (EMPhASIS)

Germany, Bulgaria, Romania, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Nephrolithiasis trials by city

Nephrolithiasis in Toronto Nephrolithiasis in Vancouver Nephrolithiasis in Montreal Nephrolithiasis in Calgary Nephrolithiasis in Edmonton Nephrolithiasis in Ottawa Nephrolithiasis in Winnipeg Nephrolithiasis in Quebec City Nephrolithiasis in Hamilton Nephrolithiasis in Kitchener Nephrolithiasis in London Nephrolithiasis in Halifax Nephrolithiasis in New York Nephrolithiasis in Los Angeles Nephrolithiasis in Chicago Nephrolithiasis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease